These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 11728253)
21. Use of generic cardiovascular medications by elderly Medicare beneficiaries receiving generalist or cardiologist care. Federman AD; Halm EA; Siu AL Med Care; 2007 Feb; 45(2):109-15. PubMed ID: 17224772 [TBL] [Abstract][Full Text] [Related]
22. Changes in the use of cardiovascular medicines in the elderly aged 75 years or older--a population-based Kuopio 75+ study. Hiitola PK; Enlund H; Sulkava RO; Hartikainen SA J Clin Pharm Ther; 2007 Jun; 32(3):253-9. PubMed ID: 17489877 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic-pharmacodynamic crisis in the elderly. ElDesoky ES Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940 [TBL] [Abstract][Full Text] [Related]
30. Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. Glintborg B; Hillestrøm PR; Olsen LH; Dalhoff KP; Poulsen HE J Clin Pharmacol; 2007 Nov; 47(11):1440-9. PubMed ID: 17962430 [TBL] [Abstract][Full Text] [Related]
31. Evidence for a gender and age inequality in the prescribing of preventative cardiovascular therapies to the elderly in primary care. Usher C; Bennett K; Feely J Age Ageing; 2004 Sep; 33(5):500-2. PubMed ID: 15315919 [No Abstract] [Full Text] [Related]
32. [Rationale for the pharmacologic treatment of cardiovascular diseases]. Perdigão C Rev Port Cardiol; 1998 May; 17(5):453-61. PubMed ID: 9656768 [TBL] [Abstract][Full Text] [Related]
33. Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees. Simon SR; Andrade SE; Ellis JL; Nelson WW; Gurwitz JH; Lafata JE; Davis RL; Feldstein A; Raebel MA J Am Geriatr Soc; 2005 Dec; 53(12):2165-9. PubMed ID: 16398903 [TBL] [Abstract][Full Text] [Related]
34. Altered pharmacodynamics of cardiovascular drugs and their relation to altered pharmacokinetics in elderly patients. Abernethy DR Clin Geriatr Med; 1990 May; 6(2):285-92. PubMed ID: 2184924 [TBL] [Abstract][Full Text] [Related]
36. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers. Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654 [TBL] [Abstract][Full Text] [Related]
37. Aging issues in drug disposition and efficacy. Sitar DS Proc West Pharmacol Soc; 2007; 50():16-20. PubMed ID: 18605223 [TBL] [Abstract][Full Text] [Related]
38. Risk and predictability of drug interactions in the elderly. Levy RH; Collins C Int Rev Neurobiol; 2007; 81():235-51. PubMed ID: 17433928 [TBL] [Abstract][Full Text] [Related]
39. Cardiac drugs: adjusting their use in aging patients. Schwartz JB; Abernethy DR Geriatrics; 1987 Aug; 42(8):31-4, 37-40. PubMed ID: 3297928 [TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamics in older adults: a review. Bowie MW; Slattum PW Am J Geriatr Pharmacother; 2007 Sep; 5(3):263-303. PubMed ID: 17996666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]